2025 Chronic Disease Consulting Diabetes 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.
GeriPal
JANUARY 16, 2025
Eric 13:00 I also love that too, because even on our inpatient ballot of care consult service, whenever somebody says that they’re unrepresented or they don’t have a surrogate, we never believe that until we usually look up. ABIM MOC credit will be offered to subscribers in November, 2025. What do I do? I think it’s.
Expert insights. Personalized for you.
66 
Let's personalize your content